Table 4.
Fit parameters, risk sensitivity index (RSI), and risk differentiability index (RDI) across the three effective dose computation methods considered in the study.
| EDLP | EOD | Er | |
|---|---|---|---|
| Slope (mSv/number of cancers per 100 patients) | 189.89 | 203.50 | 117.14 |
| R2 | 0.01 | 0.09 | 0.97 |
| Normalized RMSE | 0.55 | 0.47 | 0.12 |
| RSI | 0.81 | 0.81 | 0.99 |
| RDI (number of cancers per 100 patients) | 0.48 | 0.41 | 0.08 |
Bold text indicated the best agreement and italic indicates the poorest.